Yong Zeng

Prof. Dr. Yong Zeng

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2022 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
XLXiaoyu Liang
Xiaoyu Liang
HLHuiyang Li
Huiyang Li
AZAiai Zhang
Aiai Zhang
XTXinxin Tian
Xinxin Tian
HGHaoyang Guo
Haoyang Guo
YZYong Zeng
Yong Zeng

1 September 2025 in Journal of Hazardous Materials
Verified
Journal Article
Open access
TWTianyi Wang
Tianyi Wang
NLNa Li
Na Li
ZZZehao Zhao
Zehao Zhao
YZYang Zhang
Yang Zhang
LLLi Lin
Li Lin
YZYong Zeng
Yong Zeng
Microplastic (MP) contamination in human tissues is an emerging environmental and clinical concern, yet its relevance to organ transplantation remains poorly understood. This study characterized MPs in kidney transplantation-associated donor tissues and examined their relationship with early postoperative blood pressure (BP) in recipients. Tissue samples, including kidney, adrenal gland, renal artery, renal vein, and ureter, were collected from 28 kidney transplant donors. MPs were extracted from each tissue and analyzed using a multimodal strategy: pyrolysis-gas chromatography-mass spectrometry for polymer quantification, laser direct infrared spectroscopy (LD-IR) for particle identification, and scanning electron microscopy (SEM) for morphological assessment. Polyethylene (PE) and polyvinyl chloride (PVC) were consistently the most abundant polymers by mass, with PE concentrations ranging from 25.7 to 98.9 μg/g and PVC from 31.2 to 65.4 μg/g across tissues. LD-IR analysis showed that kidney tissue contained 293 MP particles (6 polymer types), adrenal gland 2017 (9 polymer types), renal artery 881 (8 polymer types), renal vein 1528 (10 polymer types), and ureter 1672 (10 polymer types). MPs measuring 20-100 μm accounted for 47.1-54.9 % of its content across tissues, while 100-500 μm MPs comprised 45.1-52.9 %. Postoperative BP was assessed 15 days post-transplantation. While moderate, tissue-specific correlations between certain MP types and BP were observed (e.g., natural rubber in adrenal glands, polycarbonate in renal arteries, polypropylene in renal veins, and butadiene rubber in ureters), most associations were not statistically significant. Negative values were obtained for linear regression and FDR correction, emphasizing the preliminary nature of the results. This highlights the need for further investigation of the clinical impact of MP.

25 August 2019 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
YZYu xing Zhao
Yu xing Zhao
HZHuijuan Zhu
Huijuan Zhu
HPHui Pan
Hui Pan
XLXue Mei Liu
Xue Mei Liu
LWLin Jie Wang
Lin Jie Wang
YZYong Zeng
Yong Zeng
Background and Aims. Owing to its unique anatomical structure and metabolism, epicardial adipose tissue (EAT) has attracted amount of attention in coronary artery disease (CAD) research. Here, we analyzed differences in proteome composition in epicardial (EAT) and subcutaneous adipose tissues (SAT) from patients with or without CAD. Methods. EAT and SAT samples were collected from 6 CAD patients and 6 non-CAD patients. Isobaric Tagging for Relative and Absolute Quantitation (iTRAQ) analysis combined with liquid chromatography tandem-mass spectrometry (LC-MS/MS) was performed to identify the differentially expressed proteins. Results. In total, 2348 proteins expressed in EAT and 2347 proteins expressed in SAT were separately identified. 385 differentially expressed proteins were found in EAT and 210 proteins were found in SAT in CAD patients compared to non-CAD patients. Many proteins differentially expressed in EAT of CAD patients were involved in biological functions associated with CAD development such as cell-to-cell signaling and interaction, inflammatory response, and lipid metabolism. Differential expressions of proteins (MMP9, S100A9, and clusterin) in EAT or SAT were involved in several signaling pathways such as mitochondrial dysfunction, acute phase inflammation, and LXR/RXR activation, which was confirmed by western blotting, and similar results were obtained. Conclusions. The largest profiles of differentially expressed proteins in EAT and SAT between CAD patients and non-CAD patients were identified. The significant signal pathways, mitochondrial dysfunction, and LXR/RXR activation, which differential proteins were involved in, were firstly found to play roles in EAT of CAD patients, and clusterin was firstly found to be upregulated in EAT of CAD patients.

13 May 2025 in Genes & Nutrition
Verified
Journal Article
Open access
PDF file
TWTianyi Wang
Tianyi Wang
XHXuyang Huang
Xuyang Huang
XZXinyue Zhang
Xinyue Zhang
NLNa Li
Na Li
KLKaizhi Lu
Kaizhi Lu
YZYong Zeng
Yong Zeng
Ischemic stroke remains a leading cause of mortality and disability globally, emphasizing the urgent need for innovative preventative and therapeutic strategies. Taurine, a critical amino sulfonic acid, has garnered attention for its neuroprotective effects, yet its precise role in ischemic stroke remains elusive. This study utilized a bidirectional Mendelian Randomization (MR) approach to explore the causal relationship between plasma taurine levels and ischemic stroke risk, employing genome-wide association study (GWAS) datasets. In parallel, a novel high-sensitivity liquid chromatography-tandem mass spectrometry (LC–MS/MS) method was developed to quantify plasma taurine levels in ischemic stroke patients and healthy controls. Our findings reveal a significant inverse association between taurine levels and stroke risk, with IVW analysis showing beta = -0.001 and P = 0.0085. Furthermore, LC–MS/MS analysis demonstrated that plasma taurine levels in patients with ischemic stroke were notably lower at 36.07 ± 5.37 μmol/L compared to controls at 108.66 ± 25.11 μmol/L, confirming taurine’s potential as a protective factor. These results suggest taurine as a promising biomarker and therapeutic target for stroke prevention and recovery. This study not only highlights the importance of taurine in cerebrovascular health but also provides a foundation for personalized intervention strategies.

5 August 2024 in Nutrition
Verified
Journal Article
Open access
TWTianyi Wang
Tianyi Wang
NLNa Li
Na Li
YZYong Zeng
Yong Zeng
The study investigated the causal relationships between spermidine levels and CVD risk factors using a bi-directional MR approach. Employing genetic variants from extensive GWAS datasets as IVs, the study aimed to determine whether spermidine levels can influence CVD risk factors such as blood pressure, blood glucose, and lipid profiles, and vice versa. The findings suggest a protective role of elevated spermidine levels against hypertension, elevated blood glucose, and lipid profiles (LDL-C and HDL-C). Specifically, increased spermidine levels were significantly associated with lower risk of hypertension (IVW beta = -0.0013453913, p = 0.01597648) and suppression risk of elevated blood glucose (IVW beta = -0.08061330, p = 0.02450205). Additionally, there was a notable association with lipid modulation, showing a decrease in LDL-C (IVW beta = -0.01849161, p = 0.01086728) and an increase in HDL-C (IVW beta = 0.0044608332, P = 0.01760051). Conversely, the influence of CVD risk factors on spermidine levels was minimal, with the exception that elevated blood glucose levels resulted in reduced spermidine levels. (IVW beta = -0.06714391, P = 0.01096123). These results underline the potential of spermidine as a modifiable dietary target for the prevention and management of cardiovascular diseases. Further investigations are warranted to explore the underlying biological mechanisms and the applicability of these findings in broader and diverse populations.

21 January 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
ZLZhennan Li
Zhennan Li
TXTingfeng Xu
Tingfeng Xu
ZWZhiqiang Wang
Zhiqiang Wang
YDYaodong Ding
Yaodong Ding
YZYang Zhang
Yang Zhang
YZYong Zeng
Yong Zeng
Background: Data on the predictive value of coronary computed tomography angiography–derived fractional flow reserve (CT‐FFR) for long‐term outcomes are limited. Methods and Results: A retrospective pooled analysis of individual patient data was performed. Deep‐learning‐based CT‐FFR was calculated. All patients enrolled were followed‐up for at least 5 years. The primary outcome was major adverse cardiovascular events. The secondary outcome was death or nonfatal myocardial infarction. Predictive abilities for outcomes were compared among 3 models (model 1, constructed using clinical variables; model 2, model 1+coronary computed tomography angiography–derived anatomical parameters; and model 3, model 2+CT‐FFR). A total of 2566 patients (median age, 60 [53–65] years; 56.0% men) with coronary artery disease were included. During a median follow‐up time of 2197 (2127–2386) days, 237 patients (9.2%) experienced major adverse cardiovascular events. In multivariable‐adjusted Cox models, CT‐FFR≤0.80 (hazard ratio [HR], 5.05 [95% CI, 3.64–7.01]; P <0.001) exhibited robust predictive value. The discriminant ability was higher in model 2 than in model 1 (Harrell's C‐statistics, 0.79 versus 0.64; P <0.001) and was further promoted by adding CT‐FFR to model 3 (Harrell's C‐statistics, 0.83 versus 0.79; P <0.001). Net reclassification improvement was 0.264 ( P <0.001) for model 2 beyond model 1. Of note, compared with model 2, model 3 also exhibited improvement (net reclassification improvement=0.085; P =0.001). As for predicting death or nonfatal myocardial infarction, only incorporating CT‐FFR into model 3 showed improved reclassification (net reclassification improvement=0.131; P =0.021). Conclusions: CT‐FFR provides strong and incremental prognostic information for predicting long‐term outcomes. The combined models incorporating CT‐FFR exhibit modest improvement of prediction abilities, which may aid in risk stratification and decision‐making.